FIELDS HEIDI — SEC Form 4 filings
SEC reporting owner CIK 1014330. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-20 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,658 shares, $239,316 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 1,658 shares @ $144.34 ($239,316) in AGILENT TECHNOLOGIES, INC., filed 2024-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGILENT TECHNOLOGIES, INC. (A) | Director | 3 | — | 1 leg · 1,658 sh · $239,316 | 2 |
| Icosavax, Inc. (ICVX) | — | 1 | — | — | 5 |
| Phathom Pharmaceuticals, Inc. (PHAT) | Director | 3 | — | — | 5 |
Form 4 filings — FIELDS HEIDI
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 24,122 @ $0 | EDGAR |
| 2025-06-05 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,819 @ $121.18 | EDGAR |
| 2024-05-24 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Grant/award (A): 1,678 @ $147.48 | EDGAR |
| 2024-03-07 | 4 | AGILENT TECHNOLOGIES, INC. (A) | Sale (S): 1,658 @ $144.34 | EDGAR |
| 2024-02-20 | 4 | Icosavax, Inc. (ICVX) | Code (U): 11,376 · Disposition to issuer (D): 2,917 · Disposition to issuer (D): 22,278 (derivative) · Disposition to issuer (D): 25,266 (derivative) · Disposition to issuer (D): 17,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1014330 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →